Gastric bypass leads to diabetes remission in study

10/3/2012 | InternalMedicineNews.com

Seventy-nine percent of patients with short-duration type 2 diabetes who underwent Roux-en-Y gastric bypass surgery attained disease remission, while 39% of those who had the disease for more than eight years were able to reverse diabetes, a study revealed. Researchers also found 73% of patients with short-term diabetes and 21% of those with long-term diabetes were able to discontinue their medications. The results were presented at the European Association for the Study of Diabetes meeting.

View Full Article in:

InternalMedicineNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC